{"schema_version":"secwatch.filing_event.v1","accession":"0001649094-25-000102","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2025-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.559934+00:00","generated_at":"2026-05-17T05:16:01.753661+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxcyte signs 15-year manufacturing deal with Thermo Fisher's Patheon","bullets":["Agreement covers formulation, fill, finish, testing at Patheon's Greenville, NC facility.","Binding minimum purchase commitments; termination fee in mid-eight-figures for convenience.","Initial 15-year term with auto-renewal; includes tech transfer and capex reimbursement.","Customary termination rights for cause, regulatory breach, or insolvency."],"urls":{"canonical":"https://secwatch.observer/filing/0001649094-25-000102","json":"https://secwatch.observer/filing/0001649094-25-000102.json","markdown":"https://secwatch.observer/filing/0001649094-25-000102.md","text":"https://secwatch.observer/filing/0001649094-25-000102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/0001649094-25-000102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/pcvx-20250924.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:16:01.753661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}